Raymond James & Associates’s Ovintiv OVV Stock Holding History

Raymond James & Associates’s Portfolio OVV Stock Details OVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,000	Closed	-$50K	–	4246
2021 Q3	$50K	Buy	25,000 +7,000	+39%	+$193K	﹤0.01%	3916
2021 Q2	$14K	Buy	+18,000	New	+$484K	﹤0.01%	4015
2018 Q4	–	Sell	-3,660	Closed	-$1K	–	3653
2018 Q3	$1K	Buy	3,660 +240	+7%	+$15.6K	﹤0.01%	3631
2018 Q2	$2K	Sell	3,420 -760	-18%	-$47.7K	﹤0.01%	3570
2018 Q1	$1K	Buy	4,180 +120	+3%	+$7.12K	﹤0.01%	3455
2017 Q4	$1K	Sell	4,060 -980	-19%	-$57.8K	﹤0.01%	3414
2017 Q3	$3K	Buy	+5,040	New	+$246K	﹤0.01%	3381
2017 Q1	–	Sell	-2,500	Closed	-$1K	–	3364
2016 Q4	$1K	Sell	2,500 -180	-7%	-$10.3K	﹤0.01%	3229
2016 Q3	$2K	Sell	2,680 -400	-13%	-$17.9K	﹤0.01%	3200
2016 Q2	$5K	Buy	+3,080	New	+$113K	﹤0.01%	2993

Other funds holding OVV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

SCM

Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's OVV Position: Q3 2024 in Review

Raymond James & Associates increased its Ovintiv (OVV) stake by 1.2% in Q3 2024, buying an estimated $98.4K and bringing the position to 196,518 shares worth $7.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1390.

Raymond James & Associates first reported a position in OVV in Q2 2013 and has held it in 46 quarters since. The position peaked at $10.6M in Q1 2024. 549 funds tracked by Wall St. Rank hold OVV as of Q3 2024.

Raymond James & Associates held 196,518 shares of Ovintiv worth $7.53M as of Q3 2024.
Raymond James & Associates bought 2,275 Ovintiv shares in Q3 2024, an estimated $98.4K.
Ovintiv made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1390 holding.
Raymond James & Associates first reported a position in Ovintiv in Q2 2013 and has held it in 46 quarters since.
Raymond James & Associates's Ovintiv position peaked at $10.6M in Q1 2024.
549 funds tracked by Wall St. Rank held Ovintiv as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.